...
首页> 外文期刊>Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis >Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.
【24h】

Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.

机译:大鼠血浆中功能性纤溶酶原的测定适用于溶栓实验研究。

获取原文
获取原文并翻译 | 示例

摘要

An improved sensitive, specific, precise and accurate assay of plasminogen in rat plasma was developed. It is performed in 96-well microtiter plates and can be completed within one hour. The assay is based on activation of plasminogen by human urokinase-type plasminogen activator (uPA) and simultaneous measurement of generated plasmin with the specific plasmin substrate H-D-Val-Phe-Lys-4-nitroanilide (S-2390), using purified native rat plasminogen for calibration. The concentration of S-2390 in the final reaction mixture during the whole reaction period is much greater than the Km value (approximately 20 microM) for rat plasmin-cleavage of S-2390 ensuring that hydrolysis of substrate follows zero order kinetics and that the substrate produces a 20-35 fold decrease in rate of inhibition of plasmin by its target inhibitors in plasma. Analogous to the human system the target plasma inhibitors of rat plasmin are shown to be plasmin inhibitor and alpha-macroglobulins. Tranexamic acid (0.8 mM) is incorporated in the reaction mixture resulting in a 19-fold increase in the rate of plasminogen activation and presumably an about 50-fold decrease in the rate of inhibition of generated plasmin by plasmin inhibitor. The assay is suitable for accurate measurement of plasminogen in samples obtained from animals containing pharmacological concentrations of uPA or tissue-type plasminogen activator (tPA) in their plasma when in vitro plasminogen activation is blocked at pH 5 by collecting blood in acidic anticoagulant. Judged from in vitro experiments formation of catalytic active plasmin-alpha-macroglobulin complexes during massive activation of plasminogen in vivo does not interfere with the assay.
机译:开发了一种改进的灵敏,特异,精确和准确的大鼠血浆纤溶酶原测定方法。它在96孔微量滴定板中进行,一小时内即可完成。该测定法基于人尿激酶型纤溶酶原激活剂(uPA)激活纤溶酶原,并使用纯化的天然大鼠同时测量特定纤溶酶底物HD-Val-Phe-Lys-4-硝基苯胺(S-2390)生成的纤溶酶纤溶酶原进行校准。在整个反应期间,最终反应混合物中S-2390的浓度远远大于S-2390大鼠纤溶酶裂解的Km值(约20 microM),从而确保底物的水解遵循零级动力学,并且底物血浆中的靶标抑制剂产生的纤溶酶抑制率降低20-35倍。类似于人类系统,大鼠纤溶酶的靶血浆抑制剂被证明是纤溶酶抑制剂和α-巨球蛋白。将氨甲环酸(0.8 mM)掺入反应混合物中,导致纤溶酶原激活率增加19倍,而纤溶酶抑制剂对产生的纤溶酶的抑制率大约降低50倍。当通过在酸性抗凝剂中收集血液在pH 5阻断体外纤溶酶原激活时,血浆中含有uPA或组织型纤溶酶原激活剂(tPA)的药理学浓度的动物可得该样品中的纤溶酶原。从体外实验判断,在体内大量激活纤溶酶原期间,催化活性纤溶酶-α-巨球蛋白复合物的形成不会干扰测定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号